GlassScriptPhysician profile
Jugroop S Brar
NPI 1548263825
$8,845.59
in general payments reported to CMS, 2019-2025
46 companies · $1,746 in 2025
The $1,746 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $910 · 2020: $359 · 2021: $1,044 · 2022: $1,419 · 2023: $1,750 · 2024: $1,618 · 2025: $1,746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,931 · Education: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,931.45 |
| Education | $183.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $964.26 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $901.89 | 2019-2025 | Tezspire, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $735.24 | 2019-2025 | Ofev, Jascayd |
| Actelion Pharmaceuticals US, INC. | $583.71 | 2019-2024 | Opsumit, Uptravi |
| Mylan Specialty L.P. | $575.28 | 2019-2024 | Yupelri |
| Philips North America LLC | $561.51 | 2019-2025 | (6299) Dreamwear, Vest Therapy Und |
| Electromed, INC. | $550.39 | 2019-2025 | Smartvest |
| Insmed, INC. | $388.89 | 2020-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $302.34 | 2019-2025 | Dupixent |
| United Therapeutics Corporation | $302.27 | 2019-2025 | Tyvaso, Tyvaso |
| Harmony Biosciences LLC | $298.78 | 2020-2024 | Wakix |
| Genentech USA, INC. | $265.38 | 2019-2025 | Xolair |
| Jazz Pharmaceuticals INC. | $240.12 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $203.96 | 2019-2024 | |
| Amgen INC. | $200.69 | 2021-2025 | Tezspire, Tavneos |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $190.45 | 2019-2024 | |
| Grifols USA, LLC | $177.97 | 2019-2024 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $149.18 | 2021-2025 | Glassia, Hyqvia |
| Baxter Healthcare | $144.72 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Sunovion Pharmaceuticals INC. | $132.94 | 2019-2020 | |
| Viatris Specialty LLC | $123.59 | 2025 | Yupelri |
| Merck Sharp & Dohme LLC | $120.21 | 2022-2025 | Winrevair, Belsomra |
| Mallinckrodt Hospital Products INC. | $107.49 | 2021-2024 | Acthar |
| Teva Pharmaceuticals USA, INC. | $60.40 | 2021-2022 | |
| Inspire Medical Systems, INC. | $58.61 | 2024-2025 | Inspire |
| Advanced Respiratory, INC | $49.52 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $49.25 | 2019-2023 | Xarelto |
| Pulmonx Corporation | $47.44 | 2024 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Chartis Catheter |
| Verona Pharma, INC. | $32.01 | 2025 | Ohtuvayre |
| Paratek Pharmaceuticals, INC. | $28.24 | 2021-2023 | Nuzyra |
| Alexion Pharmaceuticals, INC. | $24.43 | 2023 | Ultomiris |
| Zoll Respicardia, INC. | $24.37 | 2024 | Remede System |
| Abbvie INC. | $24.31 | 2025 | |
| Avadel Cns Pharmaceuticals, LLC | $22.34 | 2025 | Lumryz |
| Millicent US INC | $21.49 | 2024 | Intrarosa, Femring |
| Phadia US INC. | $21.24 | 2023 | Immunocap |
| Inogen, INC. | $20.29 | 2022 | |
| Abiomed | $19.20 | 2025 | |
| Breas Medical, INC. | $17.73 | 2024 | Vivo 45 Ls |
| Cook Medical LLC | $17.61 | 2025 | Blue Rhino |
| Astellas Pharma US INC | $17.28 | 2024 | Cresemba |
| Intuitive Surgical, INC. | $16.00 | 2024 | |
| Ani Pharmaceuticals, INC. | $15.56 | 2024 | Purified Cortrophin Gel |
| Tactile Systems Technology INC | $15.26 | 2024 | Entre Plus, Flexitouch Plus |
| Mayne Pharma Commercial LLC | $15.15 | 2020 | |
| Itamar Medical INC | $6.60 | 2025 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jugroop Brar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.